SMAD2
MOLECULAR TARGETSMAD family member 2
SMAD2 (SMAD family member 2) is targeted by 49 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SMAD2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About SMAD2 as a Drug Target
SMAD2 (SMAD family member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 49 compounds with documented SMAD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SMAD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.